|
Volumn 32, Issue 9, 2014, Pages 851-852
|
Sanofi to propel inhalable insulin Afrezza into market
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INSULIN;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LEGISLATION AND JURISPRUDENCE;
UNITED STATES;
ADMINISTRATION, INHALATION;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
DRUG APPROVAL;
HUMANS;
INSULIN;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84931040180
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0914-851a Document Type: Note |
Times cited : (11)
|
References (0)
|